P
ProHub
English 简体中文 繁體中文
McKinsey Medium Market Entry

Guyderma

#Beauty Products #Beauty & Personal Care #Healthcare/Pharmaceuticals #Cosmetic Surgery
ProHub Comment

This is a classic market entry case requiring analysis of market attractiveness, competitive dynamics, and operational feasibility. The candidate must navigate the tension between Guyderma's strong brand in B2C beauty products and the challenges of entering a B2B, regulated, mature market dominated by established players like Allergan. The low 1-2% growth rate is a critical red flag suggesting market saturation and limited upside.

Estimated Time 15 minutes
Difficulty Medium
Source PeterK
50 / 100
Your client is a big-name beauty product company Guyderma. They enjoy a developed product portfolio of creams, lotions, cleansers, syrups, masks and other face solutions. The CEO is entertaining the idea of branching out to a new space of solutions for plastic surgeries (e.g. botox, disport and other injection types). They need your advice on whether this might be a wise decision.

Clarifying Information

  1. Around 18M plastic procedures are done annually in the U.S.
  2. The U.S. plastic procedure space has been growing at 1-2% per year
  3. Solutions for plastic surgeries is a fairly fragmented arena, however each solution has their own dominant players (e.g. the botox segment is mostly controlled by Allergan and Ipsen Pharma)
  4. Guyderma plans to distribute their plastic surgery solutions among plastic surgeon practices in the U.S.
  5. The client didn’t provide us with any specific goals for this market expansion